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Abstract: Objectives: To optimally select chronic pain patients for different treatments, it is of
interest to identify patient characteristics that might moderate treatment effect. Our aim
was to evaluate the impact of possible moderators on the effect of acupuncture
treatment using a large data set.
Methods: We used data from an individual patient data meta-analysis of high-quality
randomized trials of acupuncture for chronic headache and migraine, osteoarthritis,
and back, neck and shoulder pain. Using meta-analytic trial-level and patient-level
regression analyses, we explored the impact of five documented patient characteristics
(patients’ age at baseline, gender, pain duration, baseline pain severity and baseline
psychological distress) on the effect of acupuncture.
Results: A total of 39 trials met the inclusion criteria: 25 use sham acupuncture controls
(n = 7,097) and 25 non acupuncture controls (n = 16,041). Of the five patient
characteristics analyzed, only baseline pain severity was found to potentially moderate
the treatment effect of acupuncture, with patients reporting more severe pain at
baseline experiencing more benefit from acupuncture compared to either sham control
or non acupuncture control. Baseline psychological distress showed small treatment
moderating effects, and results for gender were inconsistent. There was no strong
evidence that age or duration of pain influenced the response to acupuncture.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Discussion: Of five patient characteristics tested, we found only baseline severity of
pain to potentially moderate the effect of acupuncture treatment. For clinical practice,
the evidence from this analysis does not justify stratifying chronic pain patients into
subgroups that should or should not receive acupuncture on the basis of these five
characteristics. Future acupuncture trials should assess other potentially important
effect moderators.
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Dear Dr Turk 
 
Many thanks for forwarding the comments of the reviewers. Our response to each comment, 
detailing where we have made changes on the manuscript, is given below.  
 
We hope that the paper is now acceptable for publication. 
 
 
Yours sincerely 
 
Claudia Witt 
     
 
Response to Reviewers 
    
Reviewer #1 
 
Comment: Key disease characteristics such as pathophysiology of the pain conditions … 
have not been considered… chronic pain conditions such as those addressed here share 
common disease mechanisms (ie presence of neuropathic pain and/or central sensitization), 
which may or may not respond to acupuncture. Would be of interest to include some 
mechanism-based measures in future studies.  
Response: Authors response: We agree that this would be important for future research and 
have now included this suggestion into the discussion (see page XY) and conclusion section 
(see Abstract and page 12 and 14). We now say: 
 
“Some patient characteristics that might plausibly influence acupuncture effect, for 
instance, presence of neuropathic pain, were not measured in the primary trials” 
“Future trials should also assess objective variables that might either serve directly as 
acupuncture treatment effect modifiers, such as whether pain is predominately 
neuropathic or nociceptive, or markers of treatment effect, such as cytokines or genetics.” 
 
Comment: The last parameter examined in this manuscript, "psychological distress," is fairly 
vague. For example, SF-36 and SF-12 examine general psychological state but the HADS 
was is specific for depression and anxiety. There are two issues with this approach. First, it 
would have been preferred if they can address distinct psychiatric entities, such as 
depression, anxiety, sleep disorder, PTSD etc. Second, not sure if it is reasonable to 
combine the SF-36/12 AND the HADS into one general scale as they are measuring 
different things. While it may significantly compromise the sample size, it would be of interest 
to find out if anxiety or depression alone or together, as measured by the HADS, moderate 
outcomes to acupuncture.  
Response: The small number of trials with psychologic endpoints required that we combine 
different measures of psychological distress. We have added the following to the discussion 
(see page 12): 
 
“Other patient characteristics, such as psychological distress, were measured using 
inconsistent endpoints, entailing that they had to be combined in a sub-optimal manner. 
For instance, we examined the concept of psychological distress overall, rather than, for 
Response to Reviewers
example, examining anxiety and depression separately. In an observational cohort study 
of 1591 low back pain patients consulting in primary care a considerable overlap in 
psychological measures commonly used in low back pain research was confirmed 
(Conceptual overlap of psychological constructs in low back pain. Campbell P, Bishop A, 
Dunn KM, Main CJ, Thomas E, Foster NE. Pain. 2013 Sep;154(9):1783-91. doi: 
10.1016/j.pain.2013.05.035. “ 
 
 
Comment: In both the abstract and the discussions, the authors stated "the evidence from 
this analysis does not justify stratifying chronic pain patients..." The absence of evidence 
does not prove the absence of existence. In other words, responders and non-responders to 
acupuncture may still be classifiable, IF we can find the right combination of characteristics. 
Just because the set of basic characteristics examined in this manuscript did not pan out, it 
does not mean that it is not possible to stratify patients at all.  
Authors response: We have modified the conclusion of the abstract to give further 
prominence to additional research. We believe that our revised comment “we don’t have 
evidence right now to justify stratifying, but further research is needed” addresses the 
reviewer’s concern. It now reads (see Abstract): 
 
“Of five patient characteristics tested, we found only baseline severity of pain to 
potentially modify the effect of acupuncture treatment. For clinical practice, the 
evidence from this analysis does not justify stratifying chronic pain patients into 
subgroups that should or should not receive acupuncture on the basis of these five 
characteristics. Future acupuncture trials should assess other potentially important 
effect modifiers.” 
 
Comment: P8, bottom of 2nd paragraph, P=0.066, not quite meeting the conventional 
standard of statistical significance. This should be acknowledged. typo, same paragraph line 
#6, an extra "e" between "were" and "similar."  
Response: These two changes have been made (see page 9).  
     
Reviewer #2:  
 
Comment: Figure 1 and 2, please add legend to Y axis.  
Response:  This has been revised as suggested 
 
Comment: Please provide the rationale for choosing patient and disease characteristics as 
potential moderators. 
Response: This is now mentioned in the discussion section (page 12) and we have omitted 
the term disease because chronic pain is typically regarded as a disorder or symptom 
cluster. 
 
Comment: Results: This part is a bit difficult to follow. Please help explain the statistical 
results of each moderator. In the current results, some were explained and some were not. 
Response: This change has been made; we now explain or discuss the results for each 
moderator for both comparisons (see page 7, 8 and 12).  
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Abstract 
Objectives: To optimally select chronic pain patients for different treatments, it is of interest to 
identify patient characteristics that might moderate treatment effect. Our aim was to evaluate the 
impact of possible moderators on the effect of acupuncture treatment using a large data set.   
Methods: We used data from an individual patient data meta-analysis of high-quality 
randomized trials of acupuncture for chronic headache and migraine, osteoarthritis, and back, 
neck and shoulder pain. Using meta-analytic trial-level and patient-level regression analyses, 
we explored the impact of five documented patient characteristics (patients’ age at baseline, 
gender, pain duration, baseline pain severity and baseline psychological distress) on the effect 
of acupuncture. 
Results: A total of 39 trials met the inclusion criteria: 25 use sham acupuncture controls 
(n = 7,097) and 25 non acupuncture controls (n = 16,041). Of the five patient characteristics 
analyzed, only baseline pain severity was found to potentially moderate the treatment effect of 
acupuncture, with patients reporting more severe pain at baseline experiencing more benefit 
from acupuncture compared to either sham control or non acupuncture control. Baseline 
psychological distress showed small treatment moderating effects, and results for gender were 
inconsistent. There was no strong evidence that age or duration of pain influenced the response 
to acupuncture.   
Discussion: Of five patient characteristics tested, we found only baseline severity of pain to 
potentially moderate the effect of acupuncture treatment. For clinical practice, the evidence from 
this analysis does not justify stratifying chronic pain patients into subgroups that should or 
should not receive acupuncture on the basis of these five characteristics. Future acupuncture 
trials should assess other potentially important effect moderators. 
Keywords 
Effect moderators, acupuncture, chronic pain, meta-analysis 
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Introduction 
Acupuncture is commonly used to manage patients with chronic pain, and recent individual 
patient data meta-analyses including over 23,000 patients1 demonstrated that it to be more 
effective than both sham acupuncture and non-acupuncture control. However, acupuncture has 
only small specific effects1 and like all available treatments, it does not work for every chronic 
pain patient. To date, it is not well known whether and which baseline patient characteristics 
moderate the treatment effect of acupuncture. Such knowledge could be helpful for providing 
more stratified care by identifying the patients for whom acupuncture is likely to have the 
greatest effect. Knowledge about treatment-effect moderators can inform the development of 
clinical prediction rules and models of stratified care that target treatment to patient subgroups 
based on their likely response to specific treatment,2 ‘fast tracking’ patients to appropriate 
treatment and increasing healthcare efficiency.3 
Indeed, the development of Comparative Effectiveness Research4 highlights the need to identify 
possible characteristics for stratified care. However, trials are typically designed to have 
sufficient power to test a primary hypothesis and therefore are underpowered for moderator 
analyses.5,6 To detect characteristics that modify the effect of treatment on the primary outcome, 
the sample size needs to be at least four times larger than that for the primary hypothesis.7 Our 
large database,1 with individual patient data from nearly 40 randomized trials, could overcome 
this problem and allow us to explore potential acupuncture treatment effect moderators. The 
trials included in this dataset are high quality trials from different countries; the UK, Germany, 
Sweden, Spain and USA. Overall the dataset has good external validity, because it includes 
trials involving different acupuncture providers (acupuncturists, physiotherapists and medical 
doctors), different control groups (sham acupuncture, usual care, guideline-based care and no 
treatment) and different acupuncture treatment protocols (standardized, semi-standardized and 
fully individualized).  Elsewhere we have examined characteristics of acupuncture that moderate 
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treatment effects.8 Here we evaluate patient and pain characteristics as well as psychological 
distress as potential moderating factors for acupuncture treatment.  
 
Materials and Methods 
Included Trials 
Trials included in the dataset and used for these analyses were identified through a systematic 
literature review that has been previously described.1,9 The analysis included trials of 
acupuncture for chronic pain published prior to December 31, 2015 wherein allocation 
concealment was determined unambiguously to be adequate. Eligible pain types were non-
specific back or neck pain of at least four weeks duration, shoulder pain, chronic headache or 
osteoarthritis. This search resulted in the identification of potentially 44 randomized trials.  
 
Data Acquisition 
Individual patient data were obtained from only 39 trials. Data on the trial-level characteristics of 
the acupuncture intervention were obtained directly from trialists. Twenty-six trials had a sham 
acupuncture control group, and twenty-five trials had a non-acupuncture control group. One trial 
with both sham acupuncture and no acupuncture control arms was excluded from the sham 
acupuncture analysis due to a high risk of bias due to unblinding.10 
 
Outcome 
The primary outcome used for this analysis was the primary outcome defined by the study 
authors. For the 39 trials, 22 used a pain measure as primary outcome, the other trials used 
measures on function or an index measure that combines both. However, if the primary 
outcome as defined by the study authors was categorical, we used a continuous measure of 
pain taken at the same time point as the original outcome. To make the various outcome 
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measurements comparable between different trials, the primary endpoint outcome for each trial 
was standardized by dividing by pooled standard deviation. 
 
Potential treatment moderators  
The following five baseline patient characteristics were consistently available in the dataset and 
were explored as potential acupuncture treatment moderators: age at baseline, gender, pain 
duration, pain severity and psychological distress. All 39 trials collected data on baseline pain, 
with three trials reporting none of the other patient characteristics. Twenty trials had data on all 
five patient characteristics. Information on pain duration was provided by the patient and 
collected at the start of the trials. Trials that only provided information on pain duration in 
categories (i.e. more or less than 5 years) were not included in these analyses.  Baseline pain 
severity was measured using the same methods as the outcome variable. Baseline pain scores 
were standardized by dividing by the pooled standard deviation of the measure among the 
controls, separately for each trial. The measure used to capture baseline psychological distress 
varied by trial and included the mental component from the 12 and 36-item Short Form Health 
Survey (SF-12 & SF-36) and the Hospital Anxiety and Depression Scale (HADS). One trial that 
measured baseline depression on a three-point scale (inconspicuous, borderline, and 
conspicuous depression)11 was excluded since all other measures were on a continuous scale. 
In order to combine the different measures, scores were standardized in the same way as the 
outcome variable, by dividing by pooled standard deviation. 
 
Statistical Methods 
 We used two different statistical approaches to determine whether our findings were sensitive 
to the method of analysis. In the trial-level meta-analytic approach, we created a linear 
regression for each trial as for the main analysis of effect size, but also included the patient 
characteristic and an interaction term between the characteristic and treatment allocation. The 
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coefficient and standard error for the interaction term represents the change in the outcome 
score in standard deviations associated with the patient characteristic in the acupuncture 
treatment group. The coefficient and standard error were then entered into a meta-analysis, 
using the Stata command metan. For example, this trial-level analysis addresses questions 
about effect moderation such as: “Do patients who are older have a better or worse response to 
acupuncture compared to control treatment than younger patients?” Analyses were conducted 
separately for sham and non-acupuncture controls. A sensitivity analysis was conducted 
excluding a set of three outlying trials,12-14 as described in the main publication.  
In the second approach, using the patient-level, instead of testing for effect moderation in each 
trial and combining the results into a meta-analysis, we combined the 39 trials and ran a single 
regression model for each control arm comparison (non-acupuncture and sham acupuncture 
controls). The regression model included treatment arm, patient characteristic, the interaction 
between treatment and patient characteristic, and trial as a fixed effect covariate. A sensitivity 
analysis was performed using the same model adjusted for pain type (headache, osteoarthritis, 
low back pain and neck pain, or shoulder pain), rather than by individual trial. 
To model the effects of baseline pain on acupuncture treatment effect, we created separate 
models for acupuncture and control treatment groups, predicting change in pain score in terms 
of baseline pain. Restricted cubic splines with knots at the tertiles were used to allow for non-
linearity. All analyses were conducted using Stata 13 (Stata Corp., College Station, TX). 
 
Results 
Depending on the analyses, between 11 trials (n=3,828 patients) and 25 trials (n=14,222) were 
included. The effects of the five baseline patient characteristics on acupuncture treatment effect 
from the trial-level meta-analysis are shown in Table 1. In trials with a non-acupuncture control, 
pain intensity, gender and psychological distress were found to significantly moderate the 
treatment effect of acupuncture, but there were no significant effects of age or duration of pain. 
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The estimates reported in the table are the standardized difference in the effect of acupuncture 
compared to controls for each characteristic; a positive β indicates a larger effect of acupuncture 
compared to controls for patients with the given characteristic versus the referent level of the 
characteristic. For instance, the β of 0.034 for baseline psychological distress means that a 
patient with psychological distress one standard deviation higher than the mean will experience 
an improvement in pain from acupuncture of 0.034 standard deviations more than average. 
Because the average effect size for acupuncture compared to a non-acupuncture control is 
approximately 0.50 standard deviations, this means that the moderating effects of psychological 
distress and gender are relatively small. The acupuncture moderating effect of baseline pain is 
somewhat larger: the more severe the pain, the relatively greater the reduction in pain for those 
patients receiving acupuncture in comparison to control treatments. For example, a patient with 
baseline pain 2 SD more severe than the mean, experienced about 1.5 times (0.50 effect size + 
(2 SD × β 0.151) = 0.802 = approximately 1.5 fold effect) the benefit of acupuncture compared 
to a patient with a baseline pain score at the mean (Figure 1).  
 
When comparing acupuncture to sham acupuncture, baseline pain intensity and gender 
remained  statistically significant moderators of the treatment effect of acupuncture. By contrast 
psychological distress was not a treatment effect moderator when the comparison group was 
sham acupuncture. Interestingly, the acupuncture moderating effect of gender appears 
reversed, with men receiving greater reductions in pain than women, showing that the treatment 
moderating effect of gender is not consistent throughout the analyses. Moreover, age and 
duration of pain were not statistically significant effect moderators.  
In the patient-level regression analysis (Table 2), these results were similar to the meta-analytic 
model for trials with non-acupuncture control groups. However, among these trials, there was 
some evidence that the difference between acupuncture and non-acupuncture treatment was 
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larger for older patients, although this did not reach conventional levels of statistical significance 
(β 0.018 per 10 years of age, 95% CI -0.001, 0.037, p=0.066).   
In sham-controlled trials, the β values for interaction terms and p-values were similar for both 
models for most characteristics. While significant in both models, the β value for the interaction 
between baseline pain and treatment group was smaller in the patient-level regression model (β 
0.033 per 1SD vs β 0.075 per 1 SD). The β value for this interaction was smaller and non-
significant after excluding outlying trials (β 0.015 per 1SD, p=0.2). The association between 
baseline pain and pain change scores for both acupuncture and sham acupuncture groups are 
shown in Figure 1 and 2. There was evidence of an interaction in the patient-level regression 
models for two characteristics that were not seen in the meta-analytic models. First, there was 
some evidence that pain duration moderated acupuncture treatment effect in the regression 
model (β -0.026, 95% CI -0.055, 0.003, p=0.081), although this did not meet conventional levels 
of statistical significance and was sensitive to the exclusion of outlying trials (p=0.9). Second, 
baseline psychological distress significantly moderated the effect of acupuncture (β 0.054, 95% 
CI 0.005, 0.103, p=0.031).  This association is, however, small and was also highly sensitive to 
the exclusion of outlying trials (p=0.7). The patient-level models that adjusted for pain type 
rather than trial produced results consistent with the other two analyses (data not shown). 
We found that female patients who received acupuncture did better than males in trials with 
non-acupuncture control groups, while male acupuncture patients did better in trials with sham 
acupuncture controls. In an attempt to explain this finding, we performed several exploratory 
analyses. The first sensitivity analysis included only trials that used both non-acupuncture and 
sham acupuncture control arms. A total of 11 trials were included in this analysis: 3,792 patients 
in the analysis of non-acupuncture control trials, and 4,246 patients in the analysis of sham 
controlled trials. In the analysis of sham controlled trials, both the meta-analysis (β 0.159, 95% 
CI 0.039, 0.278, p=0.009) and the patient-level regression (β 0.194, 95% CI 0.078, 0.311, 
p=0.001) found a large benefit of acupuncture in male patients compared to females. In non 
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acupuncture control trials, the meta-analysis (β 0.000, 95% CI -0.125, 0.126, p > 0.9) and the 
patient-level regression (β 0.068, 95% CI -0.059, 0.195, p=0.3) found no evidence of effect 
moderation based on gender. However, effect sizes for both patient-level regression analyses 
indicated a benefit of acupuncture for males, and the effect size in sham controlled trials was 
consistent with the main analysis, indicating that the differential effect of gender seen in the 
main analysis is likely driven by the four large Acupuncture in Routine Care (ARC) trials from 
Germany. These trials with a total of 10,106 patients had only a non-acupuncture control group 
and found that women had an improved response to acupuncture compared to men.15 
To investigate this further, we then performed a sensitivity analysis excluding those 10,106 
patients. In this sensitivity analysis, the β for the interaction between gender and acupuncture 
group from the meta-analysis for non-acupuncture control was again non-significant and close 
to the null (β -0.003, 95% CI -0.106, 0.101, p > 0.9). In the patient-level regression model, the β 
for the 5,202 patients remaining in the analysis was in the same direction as the effect seen in 
sham trials, but the effect size was small compared to the effect seen in the sham analysis and 
was not statistically significant (β 0.036, 95% CI -0.069, 0.140, p=0.5).  
In previous papers8,9 we found evidence that an increased number of acupuncture needles or 
acupuncture treatment sessions could improve the benefit of acupuncture. Based on our 
analysis which found an increased benefit of acupuncture for those with higher baseline pain, 
we then investigated whether patients with the highest levels of baseline pain received higher 
doses of acupuncture, that is, whether the association between baseline pain and outcome was 
confounded by patients reporting high pain levels being given more acupuncture. We created 
linear regression models with baseline pain severity as a covariate for two outcomes: average 
number of acupuncture needles used per session and total number of acupuncture sessions. 
Models were created separately for each trial and included only patients in the acupuncture 
group. Since only patients in the acupuncture group were eligible, both non-acupuncture and 
sham acupuncture-controlled trials were included. For each outcome, the coefficient and 
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standard error for baseline pain were saved out from each trial and entered into a meta-
analysis. 
We found a statistically but not clinically significant association between baseline pain and 
number of acupuncture sessions, with an overall estimate of an additional 0.10 sessions 
associated with a 1SD increase in baseline pain (95% CI 0.04, 0.15, p=0.001). There was no 
evidence of an association between baseline pain and average number of needles used per 
session (0.014 needles per 1SD increase in baseline pain, 95% CI -0.16, 0.19, p=0.9). 
 
Discussion 
Findings 
Patients with chronic pain participating in acupuncture trials respond differently to the 
acupuncture treatment. We evaluated five possible acupuncture treatment effect moderators. By 
using individual patient data meta-analyses on a large international data set of randomized trials 
we were able to conduct well-powered analyses. Furthermore, we employed several secondary 
analyses to check our results for robustness.  
Of the five patient variables available in the dataset, only baseline pain severity was found to 
have a consistent moderating effect on acupuncture outcomes, patients reporting more severe 
pain at baseline experiencing more benefit from acupuncture than comparison treatments. The 
size of these effects varied with the control groups used: larger effects were observed when 
patients were not blinded to the intervention. Age or duration of pain do not seem to moderate 
the response to acupuncture. In several analyses, baseline psychological distress showed small 
acupuncture treatment moderating effects. The most inconsistent results were found for gender 
showing that men benefit more from acupuncture in sham controlled trials and women more in 
non-acupuncture group controlled trials. Sensitivity analyses showed that the moderating effect 
of female gender was mainly driven by four large open label trials from one country and not 
consistent for other trials.  
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Advantages and limitations 
Our results are based on a very large dataset consisting of high quality randomized trials from 
different countries, providers and acupuncture protocols. In contrast to typical meta-analyses, 
individual patient data allows for sensitivity analyses with adjustment for the trial and type of 
chronic pain to examine the robustness of our conclusions. To identify possible characteristics 
associated with patients that could lead to stratified care, we wanted to examine as many 
possible characteristics. The  main limitation was data availability. We could only examine the 
five baseline variables (age, gender, pain duration, pain severity and psychological distress) that 
were available in a standardised format for most of the trials.  Additional patient characteristics 
that might plausibly influence acupuncture effect, for instance, presence of neuropathic pain, 
were not measured in the primary trials. Other patient characteristics, such as psychological 
distress, were measured using inconsistent endpoints, requiring that they had to be combined in 
a sub-optimal manner. For instance, we examined the properties of psychological distress 
overall, rather than,  examining anxiety and depression separately. In an observational cohort 
study of 1591 low back pain patients consulting in primary care a considerable overlap in 
psychological measures commonly used in low back pain research was confirmed .16 Yet other 
important patient characteristics, that potentially may be moderators of the effects of 
acupuncture compared to other treatments such as level of education, pain catastrophizing and 
self-efficacy could not be examined in the analyses, because these constructs were collected in 
very different ways in different studies and were not collected at all in many trials. However, 
results of a pooled analysis using four German-based trials, all of which are included in our 
study, found that level of education predicted the outcome independent of the intervention and 
was therefore not an acupuncture effect moderator.15 Because the number of older adults in the 
data set was limited, the findings that the difference between acupuncture and non-acupuncture 
treatment might be larger for older adults should be interpreted with caution.   
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Comparison with other studies  
We found that patients with more severe pain at baseline improved more from acupuncture 
treatment than those with lower levels of pain, compared to other treatments. Previous studies 
have reported baseline pain to predict the outcome independent of the intervention and not, as 
in our current analysis, as a treatment effect moderator.15,17,18 Such trials explained effects in 
terms of regression to the mean, or to floor effects at baseline, which diminish the possibility of 
improvements in pain levels as a result of treatment. Overall the evidence for mediating factors 
for treatments in musculoskeletal pain populations is still limited.19  
 
In these meta-analyses, baseline psychological distress was a statistically significant treatment 
effect moderator in several analyses. Patients with greater psychological distress at baseline 
experienced greater benefit from acupuncture. This is the first time this effect has been 
identified for acupuncture treatment. However, the effect is small and of questionable clinical 
relevance.  As a result, exclusion of patients with low psychological distress from acupuncture 
treatment or acupuncture trials cannot be justified. 
That age and pain duration did not moderate the treatment outcome is in agreement with 
previous acupuncture studies.15 The influence of gender on pain reduction was inconsistent and 
seemed to depend on the types of trials included into the analyses. When excluding the large 
German trials with a non-acupuncture control it seems that men benefit more, however, this was 
mainly based on sham-controlled data. Because of the inconsistency of the data and the overall 
small size of the treatment moderating effect the current evidence does not justify using gender 
as stratification factor in clinical practice. 
 
Implications for research and practice  
Future acupuncture trials should assess other potentially important effect moderators, such as 
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treatment outcome expectation20 and pain self-efficacy21, that were only available for very few 
trials in our data set. Future trials should also assess objective variables that might either serve 
directly as acupuncture treatment effect moderators (e.g., whether pain is predominately 
neuropathic or nociceptive) or serve as markers of treatment effect, such as cytokines or 
genetics. For clinical practice the current evidence provides no justification for stratifying 
patients in groups that should or should not receive acupuncture. 
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Figure legend 
Figure 1: Change in pain from baseline in non-acupuncture controlled trials 
Figure 2: Change in pain from baseline in sham-controlled trials 
Table 1. Trial-Level Fixed-Effects Meta-Analysis. The β can be interpreted as the difference in the effect of acupuncture in standard deviations. 
For instance, the β of -0.079 for male gender in trials with non acupuncture control means that, on average, the difference between acupuncture 
and non acupuncture was 0.079 standard deviations lower for men 
 
 FIXED EFFECTS: Coefficients for interaction terms 
 ACUPUNCTURE VS. NON-ACUPUNCTURE ACUPUNCTURE VS. SHAM 
 Number 
of 
trials 
included 
β 95% CI p 
Number 
of 
trials 
included 
β 95% CI p 
Baseline pain intensity (per 1 SD) 25 0.151 0.126, 0.177 <0.0001 25 0.073 0.030, 0.117 0.001 
     Excluding outlying trials     22 0.073 0.027, 0.119 0.002 
Age (per 10 years)   25 -0.012 -0.033, 0.008 0.2 22 0.030 -0.010, 0.069 0.14 
     Excluding outlying trials     19 0.022 -0.019, 0.064 0.3 
Male 25 -0.079 -0.134, -0.024 0.005 22 0.151 0.052, 0.250 0.003 
     Excluding outlying trials     19 0.152 0.049, 0.255 0.004 
Duration (per 5 years) 18 -0.002 -0.017, 0.014 0.8 16 0.005 -0.027, 0.037 0.8 
     Excluding outlying trials     13 0.002 -0.031, 0.035 0.9 
Baseline psychological distress (per 1 SD) 20 0.034 0.007, 0.061 0.013 13 -0.022 -0.077, 0.033 0.4 
     Excluding outlying trials     11 -0.018 -0.074, 0.039 0.5 
Table 1
Table 2. Patient-Level Regression Analysis for Effect Moderators, adjusting for trial. The β can be interpreted as the difference in the effect 
of acupuncture in standard deviations. For instance, the β of -0.057 for male gender in trials with non acupuncture control means that, on average, 
the difference between acupuncture and non acupuncture was 0.057 standard deviations lower for men.  
 Regression Coefficients for Interaction Terms 
 ACUPUNCTURE VS. NO ACUPUNCTURE ACUPUNCTURE VS. SHAM 
 Number of 
trials 
(patients) 
included 
β 95% CI p 
Number of 
trials 
(patients) 
included 
β 95% CI p 
Baseline pain intensity (per 1 SD) 25 (14,222) 0.139 0.118, 0.159 <0.0001 25 (6,597) 0.033 0.009, 0.057 0.006 
     Excluding outlying trials     22 (5,985) 0.015 -0.010, 0.039 0.2 
Age (per 10 years)   25 (14,218) 0.018 -0.001, 0.037 0.066 22 (6,392) 0.024 -0.006, 0.053 0.11 
     Excluding outlying trials     19 (5,780) 0.013 -0.017, 0.042 0.4 
Male  25 (14,222) -0.057 -0.114, -0.001 0.047 22 (6,398) 0.137 0.039, 0.234 0.006 
     Excluding outlying trials     19 (5,786) 0.176 0.076, 0.276 0.001 
Duration (per 5 years) 18 (12,386) -0.005 -0.020, 0.010 0.5 16 (4,572) -0.026 -0.055, 0.003 0.081 
     Excluding outlying trials     13 (3,960) 0.001 -0.029, 0.031 0.9 
Baseline psychological distress (per 1 
SD) 
20 (12,531) 0.030 0.004, 0.056 0.025 13 (4,031) 0.054 0.005, 0.103 0.031 
     Excluding outlying trials     11 (3,828) 0.012 -0.039, 0.062 0.7 
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